Lamin A/C dysregulation contributes to cardiac pathology in a mouse model of severe spinal muscular atrophy

Darija Šoltić, Hannah K. Shorrock, Hazel Allardyce, Emma L. Wilson, Ian Holt, Silvia A. Synowsky, Sally L. Shirran, Simon H. Parson, Thomas H. Gillingwater, Heidi R. Fuller (Corresponding Author)

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
3 Downloads (Pure)


Cardiac pathology is emerging as a prominent systemic feature of spinal muscular atrophy (SMA), but little is known about the underlying molecular pathways. Using quantitative proteomics analysis, we demonstrate widespread molecular defects in heart tissue from the Taiwanese mouse model of severe SMA. We identify increased levels of lamin A/C as a robust molecular phenotype in the heart of SMA mice, and show that lamin A/C dysregulation is also apparent in SMA patient fibroblast cells and other tissues from SMA mice. Lamin A/C expression was regulated in-vitro by knockdown of the E1 ubiquitination factor UBA1, a key downstream mediator of SMN-dependent disease pathways, converging on β-catenin signalling. Increased levels of lamin A are known to increase the rigidity of nuclei, inevitably disrupting contractile activity in cardiomyocytes. The increased lamin A/C levels in the hearts of SMA mice therefore provide a likely mechanism explaining morphological and functional cardiac defects, leading to blood pooling. Therapeutic strategies directed at lamin A/C may therefore offer a new approach to target cardiac pathology in SMA.
Original languageEnglish
Pages (from-to)3515–3527
Number of pages13
JournalHuman Molecular Genetics
Issue number21
Early online date9 Aug 2019
Publication statusPublished - 1 Nov 2019

Bibliographical note

The authors would like to thank Prof Colin L Stewart, Institute of Medical Biology,
Singapore, for kindly providing wild type and LMNA knockout mouse embryonic fibroblasts, and Prof Glenn E Morris for helpful discussions about lamin A and for providing access to laboratory equipment. This research was supported by funding from the Newlife Charity [SG/15-16/11] (HF) and Keele University ACORN funding (HF & DS); British Heart Foundation [PG/16/68/31991] (IH); UK SMA Research Consortium (SMA Trust) (THG) and the Euan MacDonald Centre for Motor Neurone Disease Research (HKS and THG); and Wellcome Trust [094476/Z/10/Z] (SLS).


Dive into the research topics of 'Lamin A/C dysregulation contributes to cardiac pathology in a mouse model of severe spinal muscular atrophy'. Together they form a unique fingerprint.

Cite this